Design and Rationale for the Direct Oral Anticoagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) Study. Dimond M, Looby M, Shah B, Sinha SS, et al. J Card Fail 2024;30:819-828.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dimond M, Looby M, Shah B, Sinha SS, et al. Design and Rationale for the Direct Oral Anticoagulant Apixaban in Left Ventricular Assist Devices (DOAC LVAD) Study. J Card Fail 2024;30:819-828.
PMID: 37956897